PARIS--(BUSINESS WIRE)--While the French biotechnology industry has been hit by the temerity of stock market investors, the launch of Euronext’s Next Biotech Index provides greater visibility for the sector, thereby rendering it more attractive. Growth and innovation are both evident in the product and service portfolio of the French biotech sector.
